Humira

Watch Out AbbVie, Here Comes Celgene
Motley Fool
Wed, 03/26/14 - 12:45 pm
Celgene
AbbVie
Humira
Stelara
Otezla
The 10 best-selling drugs of 2013
Fierce Pharma
Tue, 03/25/14 - 10:07 am
Seretide
Rituxan
Remicade
MabThera
Lantus
Humira
Herceptin
Enbrel
Crestor
Avastin
Advair
Abilify
FirstWord Lists – Pharma's 50 biggest selling drugs: AbbVie's Humira joins the $10 billion club
First Word Pharma
Mon, 03/10/14 - 11:56 am
prescription data
Humira
AbbVie
AbbVie's Humira Still a Growth Engine
Motley Fool
Sun, 03/9/14 - 01:35 pm
AbbVie
Humira
rheumatoid arthritis
psoriasis
Sandoz starts late-stage trial with copy of AbbVie's Humira drug
Yahoo/AP
Wed, 12/18/13 - 05:14 pm
Sandoz
generics
Humira
AbbVie
biosimilars
Novartis
Celgene Vs. Rivals In Psoriatic Arthritis Drug Race
Seeking Alpha
Wed, 11/20/13 - 08:29 am
psoriatic arthritis
Celgene
AbbVie
Amgen
JNJ
Merck
Humira
apremilast
Enbrel
Stelara
Simponi
Remicade
Bristol-Myers Vs. Abbvie In Potential Humira Rivalry
Seeking Alpha
Mon, 11/4/13 - 09:47 am
AbbVie
Humira
Bristol-Myers Squibb
clazakizumab
The 3 Best-Selling Drugs in the World
Motley Fool
Mon, 10/21/13 - 08:24 am
AbbVie
Humira
Remicade
JNJ
GSK
Advair
Knockoff Lust: AbbVie's $9 Billion-A-Year Humira
Seeking Alpha
Wed, 10/9/13 - 08:25 am
AbbVie
Humira
JNJ
Amgen
rheumatoid arthritis
How AbbVie Plans to Survive After Humira
Motley Fool
Fri, 09/27/13 - 08:20 am
AbbVie
Humira
Ablynx
ALX-0061
Top 10 rheumatoid arthritis drugs 2013
Fierce Pharma
Wed, 09/18/13 - 10:27 am
rheumatoid arthritis
Humira
AbbVie
Enbrel
Amgen
Remicade
Janssen
Celebrex
Pfizer
Bristol-Myers Squibb
Orencia
Cimza
UCB
Simponi
JNJ
Arthrotec
Vimovo
AstraZeneca
Kineret
[video]Patent Expirations AbbVie Investors Need to Watch
Motley Fool
Tue, 09/17/13 - 11:49 am
AbbVie
Humira
patents
patent expirations
[video]What Are the Main Threats to AbbVie's Humira?
Motley Fool
Mon, 09/9/13 - 05:15 pm
AbbVie
Humira
Pfizer
Xeljanz
Human Hair Found in IV Solution Prompts Hospira Recall
Regulatory Focus
Wed, 09/4/13 - 01:12 pm
Humira
recalls
Aminosyn
Understanding the Massive Market Potential of Monoclonal Antibodies
Motley Fool
Wed, 08/28/13 - 04:53 pm
monoclonal antibodies
Roche
Herceptin
Rituxan
Avastin
GSK
Amgen
Eli Lilly
Bristol-Myers Squibb
Seattle Genetics
Adcetris
Kadcyla
bapineuzumab
Elan
JNJ
Pfizer
necitumumab
AbbVie
Humira
The 5 Best-Selling Medications of 2013 (So Far)
Motley Fool
Tue, 08/6/13 - 11:24 am
AbbVie
Humira
Advair
GSK
Seretide
Enbrel
Amgen
Pfizer
Lantus
Sanofi
Avastin
Roche
FDA advisory panel votes against new use of AbbVie's Humira
Reuters
Wed, 07/24/13 - 09:51 am
FDA
advisory panels
AbbVie
Humira
spondyloarthritis
Successor To Humira? AbbVie And Galapagos Work On It
Seeking Alpha
Tue, 06/18/13 - 08:54 am
Humira
AbbVie
Galapagos
GLPG0634
Chron's Disease
Incyte
Eli Lilly
Pfizer
rheumatoid arthritis
Is This GlaxoSmithKline's Next Big Blockbuster?
Motley Fool
Fri, 06/7/13 - 05:47 pm
rheumatoid arthritis
GSK
Humira
AbbVie
MOR103
MorphoSys
Celgene: Apremilast For Psoriatic Arthritis Offers Upside
Seeking Alpha
Tue, 05/14/13 - 05:22 pm
apremilast
psoriatic arthritis
Celgene
AbbVie
Amgen
JNJ
Remicade
Enbrel
Humira

Pages